DK0445460T3 - Mikroorganisme til selektiv fremstilling af en specifik bestanddel af avermectin og fremgangsmåde til fremstilling deraf - Google Patents
Mikroorganisme til selektiv fremstilling af en specifik bestanddel af avermectin og fremgangsmåde til fremstilling derafInfo
- Publication number
- DK0445460T3 DK0445460T3 DK90308842.5T DK90308842T DK0445460T3 DK 0445460 T3 DK0445460 T3 DK 0445460T3 DK 90308842 T DK90308842 T DK 90308842T DK 0445460 T3 DK0445460 T3 DK 0445460T3
- Authority
- DK
- Denmark
- Prior art keywords
- avermectin
- preparation
- microorganism
- acid
- specific constituent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
- C12N15/03—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2053411A JP2888586B2 (ja) | 1990-03-05 | 1990-03-05 | エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0445460T3 true DK0445460T3 (da) | 1995-08-14 |
Family
ID=12942087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90308842.5T DK0445460T3 (da) | 1990-03-05 | 1990-08-10 | Mikroorganisme til selektiv fremstilling af en specifik bestanddel af avermectin og fremgangsmåde til fremstilling deraf |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5206155A (fr) |
| EP (1) | EP0445460B1 (fr) |
| JP (1) | JP2888586B2 (fr) |
| AT (1) | ATE123805T1 (fr) |
| AU (1) | AU629966B2 (fr) |
| CA (1) | CA2023114C (fr) |
| DE (1) | DE69020138T2 (fr) |
| DK (1) | DK0445460T3 (fr) |
| ES (1) | ES2075881T3 (fr) |
| NZ (1) | NZ234741A (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6103504A (en) * | 1992-03-25 | 2000-08-15 | Pfizer Inc. | Process for production of avermectins and cultures therefor |
| IT1255135B (it) * | 1992-05-05 | 1995-10-20 | Principio attivo a base di avermectine, ceppo e procedimento per la sua preparazione e composizione veterinaria che lo contiene. | |
| US5292647A (en) * | 1992-11-30 | 1994-03-08 | Eli Lilly And Company | Strain of streptomyces for producing avermectins and processes therewith |
| DE69415675T2 (de) * | 1993-07-23 | 1999-05-20 | Pfizer Inc., New York, N.Y. | Verfahren zur Ausfällung von natürlichen Avermectinen, sowie Fermentationsverfahren zur Herstellung derselben |
| CN1521180A (zh) * | 1998-02-13 | 2004-08-18 | �Ʒ� | 介导除虫菌素b2:b1比例的除虫链霉菌基因 |
| CA2362253C (fr) | 1999-02-09 | 2008-09-23 | The Kitasato Institute | Derives de l'avermectine |
| JP2000245457A (ja) * | 1999-02-24 | 2000-09-12 | Kitasato Inst:The | エバーメクチンアグリコン合成酵素遺伝子 |
| CA2418968C (fr) | 2000-08-09 | 2009-11-24 | The Kitasato Institute | Derives d'avermectine |
| JPWO2002012248A1 (ja) | 2000-08-09 | 2004-01-15 | 社団法人北里研究所 | エバーメクチン誘導体 |
| CN101429536B (zh) * | 2008-12-15 | 2011-09-14 | 浙江升华拜克生物股份有限公司 | 一种采用全孢子接种工艺生产阿维菌素的方法 |
| WO2015135242A1 (fr) | 2014-03-10 | 2015-09-17 | 浙江海正药业股份有限公司 | Microorganisme recombiné exprimant un analogue de l'avermectine et son utilisation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US4429042A (en) * | 1978-09-08 | 1984-01-31 | Merck & Co., Inc. | Strain of Streptomyces for producing antiparasitic compounds |
| IN167980B (fr) * | 1987-01-23 | 1991-01-19 | Pfizer | |
| DE3881147T2 (de) * | 1987-10-23 | 1993-09-02 | Pfizer | Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen. |
-
1990
- 1990-03-05 JP JP2053411A patent/JP2888586B2/ja not_active Expired - Fee Related
- 1990-08-01 NZ NZ234741A patent/NZ234741A/en unknown
- 1990-08-06 AU AU60201/90A patent/AU629966B2/en not_active Ceased
- 1990-08-10 AT AT90308842T patent/ATE123805T1/de not_active IP Right Cessation
- 1990-08-10 ES ES90308842T patent/ES2075881T3/es not_active Expired - Lifetime
- 1990-08-10 DK DK90308842.5T patent/DK0445460T3/da active
- 1990-08-10 CA CA002023114A patent/CA2023114C/fr not_active Expired - Fee Related
- 1990-08-10 EP EP90308842A patent/EP0445460B1/fr not_active Expired - Lifetime
- 1990-08-10 US US07/565,448 patent/US5206155A/en not_active Expired - Lifetime
- 1990-08-10 DE DE69020138T patent/DE69020138T2/de not_active Expired - Fee Related
-
1992
- 1992-12-30 US US07/998,861 patent/US5369021A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2888586B2 (ja) | 1999-05-10 |
| DE69020138D1 (de) | 1995-07-20 |
| AU6020190A (en) | 1991-09-05 |
| NZ234741A (en) | 1992-03-26 |
| JPH03254678A (ja) | 1991-11-13 |
| CA2023114C (fr) | 1996-12-17 |
| US5206155A (en) | 1993-04-27 |
| EP0445460B1 (fr) | 1995-06-14 |
| AU629966B2 (en) | 1992-10-15 |
| CA2023114A1 (fr) | 1991-09-06 |
| ES2075881T3 (es) | 1995-10-16 |
| ATE123805T1 (de) | 1995-06-15 |
| EP0445460A1 (fr) | 1991-09-11 |
| DE69020138T2 (de) | 1995-12-14 |
| US5369021A (en) | 1994-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7773891A (en) | High-strength, thin-walled single piece catheters | |
| NO993247D0 (no) | FremgangsmÕte for fremstilling av tolterodin | |
| CA2072573A1 (fr) | Traitement d'infections a retrovirus humain a l'aide de la 2',3'-didesoxyinosine | |
| EP0798285A3 (fr) | Acide 3,4,4-trifluoro-3-buténoique ou son esterméthylique | |
| MX9100448A (es) | Clatratos de peroxiacidos | |
| AU629966B2 (en) | A microorganism for selective production of specific component of avermectin and a method for selective production thereof | |
| AU7736191A (en) | Oxazolidinones | |
| CA2011452A1 (fr) | Compose pharmaceutique contenant un vecteur acceptable en pharmacologie et un compose de (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-19-pregn-5-(10)-en-20-yn- 3-one | |
| MD1788F2 (en) | Erythromycin A 9-O-oximes derivatives, pharmaceutical composition on base thereof and method of treatment of infectious diseases | |
| FI891581A0 (fi) | Peptidderivat. | |
| EP0668316A3 (fr) | Composition de résine de chlorure de polyvinyle et procédé de sa préparation. | |
| AU642259B2 (en) | Novel 3,3'-dithiobis (propionic acids) and esters thereof | |
| BR9304843A (pt) | Cultura biologicamente pura do microorganismo de streptomyces avermitilis, processo para produzir pelo menos um composto de avermectina e avermectina assim produzida, processo para produzir ivermectina e ivermectina assim produzida. | |
| DZ1687A1 (fr) | Procédé d'extraction par membrane. | |
| MX9204520A (es) | Proceso para la preparacion de natamicina por fermentacion (caso ch 2074). | |
| KR950700988A (ko) | 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof) | |
| SE9200428L (sv) | Nytt antitumörantibiotikum | |
| NO178235C (no) | Fremgangsmåte for mikrobiologisk fremstilling av L-carnitin | |
| TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
| FI913699A0 (fi) | Menetelmä farmaseuttisesti käyttökelpoisten 4'-epi-4'-aminoantrasykliinien valmistamiseksi sekä menetelmässä käytettävät välituotteet | |
| FI900665A0 (fi) | Derivat av 3-pyroglutamyl-tiatsolidin -4-karboxylsyra och deras farmakologiska egenskaper. | |
| DE3880088D1 (de) | Ethylierte avermectine. | |
| DE69116057D1 (de) | Mikrobische Herstellung des 13-beta-13-deoxy-22,23,-dihydroavermectin-Bla/B1b-Aglycons | |
| EP0083019A3 (fr) | Procédé d'obtention de glycosides anthracycliques optiquement actifs, les 4-désoxy-aclacinomycines A et B, et leurs préparations pharmaceutiques | |
| DK0747486T3 (da) | Mikrobiologisk fremgangsmåde til fremstilling af heteroaromatiske carboxylsyrer ved hjælp af mikroorganismer af slægten Alc |